What is Cardiff Oncology, Inc. (CRDF)?
Cardiff Oncology, Inc. is a clinical-stage biopharmaceutical company focused on the development of targeted therapies for cancer and other diseases. The company specializes in the research and development of novel compounds that modulate specific molecular pathways involved in tumor growth and progression. Cardiff Oncology's pipeline includes drug candidates designed to address unmet medical needs in oncology, with an emphasis on precision medicine approaches. The company employs a strategy of advancing its therapeutics through clinical trials to evaluate safety and efficacy. It collaborates with academic institutions and industry partners to support its research initiatives. Cardiff Oncology operates within the biotechnology sector, contributing to the broader effort to develop innovative cancer treatments. Its activities encompass drug discovery, clinical development, and regulatory engagement aimed at bringing new therapies to patients.
Cardiff Oncology, Inc. Stock Price Today: Live Overview
The price today is shaped by trading session developments, with Cardiff Oncology, Inc. at $1.7500. Its price has fluctuated between $1.7 and $1.775, showing a daily change of 0%.
FAQ: Cardiff Oncology, Inc. (CRDF)
What is the current price of CRDF stock?
The current price stands at $1.7500.
Does CRDF pay dividends?
Cardiff Oncology, Inc. does not pay dividends.
Does CRDF have a formal corporate presence or regional headquarters in the UAE?
Cardiff Oncology, Inc. operates via partners and distributors in the UAE without an official regional office or subsidiary.
What is CRDF best known for?
Cardiff Oncology, Inc. is most famous for its development of cancer therapies.
What assets are typically shown together with CRDF?
Commonly shown alongside CRDF: Link REIT, Jersey Electricity PLC, Kirin Holdings Company, Limited
Latest shares articles



